SomaLogic, Inc.
NASDAQ:SLGC
Overview | Financials
Company Name | SomaLogic, Inc. |
Symbol | SLGC |
Currency | USD |
Price | 2.1 |
Market Cap | 396,225,917 |
Dividend Yield | 0% |
52-week-range | 1.73 - 3.79 |
Industry | Health Information Services |
Sector | Healthcare |
CEO | Mr. Adam Taich |
Website | https://www.somalogic.com |
An error occurred while fetching data.
About SomaLogic, Inc.
SomaLogic, Inc. operates as a protein biomarker discovery and clinical diagnostics company in the United States. It develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for their cognate protein; and offers proprietary SomaScan services, which provide multiplex protein detection and quantification
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD